It's possible to predict some violent public protests by tracking social media posts on moral outrage over a triggering event. Tracy Le Blanc/Pexels

Every grade school teacher knows that student conduct can get out of hand, fast, when a group of kids eggs on one individual. Time-outs are a testimony to the power of isolating one 10-year-old from a choir of buddies.

Social media plays a role similar to a gang of hyped-up grade schoolers, providing a community that can express collective disapproval of people or events. When this disapproval has a moral cast ⁠— for example, after a police shooting or the removal of a statue ⁠— the social network's particular characteristics are key predictors about whether that disapproval will turn violent.

There is a word for the way group support of a belief system makes it seem worth fighting for: moralization. Tracking social network activity now makes it possible to measure the chances for an individual belief to become moralized by a group ⁠— a phenomenon known as moral convergence.

In a recent study in Nature, Rice Business professor Marlon Mooijman, then at the Kellogg School of Management, joined a team that analyzed when and how violence erupts in protests. In a series of observation and behavior experiments that mixed psychology, organizational theory and computer science, they accurately predicted how violence is influenced by group discussion of moral views on social media.

The researchers started by studying the number and content of tweets linked to the Baltimore riots in 2015, after the death of Freddie Gray in police custody. The researchers then compared these tweets with the number of arrests in a given time frame, using a methodology developed by Marlon Mooijman and Joe Hoover from the Brain and Creativity Institute at the University of Southern California.

To analyze the tweets responding to Gray's death, they first separated them into two sets: Those with moral commentary and those without moral judgments.

Next, the researchers tracked whether tweets with moral content increased on days with violent protests. Violence was measured using the number of police arrests, which the researchers compared with the specific time frames of moral tweets.

There was no major difference in the overall tweet traffic discussing Freddie Gray's death on days with violent protests and on peaceful days. The number of moralizing tweets, however, clearly correlated with episodes of violent protests, rising to nearly double the moralizing tweets on days with no violence.

This raised a provocative question. Were morally ⁠— based tweets a response to the events of the day ⁠— or were they somehow driving the violence?

To find out, Mooijman and Hoover worked with computer scientists Ying Lin and Jeng Ji of Rensselaer Polytechnic Institute and Morteza Dehghani of the University of Southern California to develop algorithms that could establish mathematical probabilities for the results.

For every single-unit increase in moral tweets over a 4-hour period, the researchers found, there was a .25 corresponding increase in arrests.

The researchers then tried to measure the effect similar moral views ⁠— such as a social media page with self-selected members of a similar political affiliation ⁠— had on violence during protests.

To do so, they set up a second study, which measured participant reactions to the protestors of a far-right rally in Charlottesville, Virginia in 2017. Participants ranked their level of agreement over the morality of protesting the rally.

There was a direct relationship between believing a protest action was moral, the researchers found, and finding violence at that protest acceptable. This relationship held true throughout the study, regardless of political orientation.

The researchers' next goal was to identify the impact of exposure to people of like beliefs. To do this, participants rated their feelings when they were told that most people in the U.S. shared their views. While the intensity of participants' moral views created the potential for violence, the researchers found, violence resulted when only actively validated by others with similar views.

Having one's moral outrage supported by others on social media, the professors concluded, may explain the spike in violence in recent protests.

While respect for privacy remains critical, governments and law enforcement can use the social media trend to pinpoint the moments when moral outrage can turn deadly. Perhaps most importantly, however, the research also suggests practical tactics for calming violent tendencies before they get out of control. To reduce real-life protest violence, they wrote, it's critical that social media sites include a variety of voices. It's another reason, if any were needed, that a bit of judicious exposure to other views is healthy for everyone.

------

This story originally ran on Rice Business Wisdom.

Marlon Mooijman is an assistant professor of Organizational Behavior. He teaches in the undergraduate business minor program and MBA full-time program.

Ad Placement 300x100
Ad Placement 300x600

CultureMap Emails are Awesome

NASA unveils Artemis III astronauts at Johnson Space Center in Houston

To the moon

NASA on Tuesday, June 9, revealed the crew for its Artemis III mission, the next step in the space agency's plan to eventually land astronauts on the moon.

The announcement came two months after Artemis II's record-breaking trip around the moon that surpassed the distance record of Apollo 13.

NASA's Randy Bresnik, Frank Rubio, Andre Douglas and the European Space Agency's Luca Parmitano won't fly to the moon or land on the surface. Instead, they’ll orbit Earth while practicing docking their Orion capsule with two lunar landers.

“To the Artemis III crew, we wish you Godspeed on the journey ahead,” said NASA administrator Jared Isaacman.

Elon Musk’s SpaceX and Jeff Bezos’ Blue Origin are racing to deliver the lunar landers. The two-week demo is targeted for 2027. Blue Origin suffered a recent setback when its massive rocket exploded during an engine-firing test on the launch pad in Florida, shaking nearby homes and illuminating the sky with an orange fireball.

NASA's Jeremy Parsons said the setback is a learning opportunity and that the space agency is confident Blue Origin's rocket will be ready in time.

NASA's Artemis program aims to return astronauts to the moon's surface for the first time since the 1970s. A recent revamp of the program announced by Isaacman aims to fast-track it similarly to the Apollo era, adding the upcoming spaceflight around Earth before eyeing a lunar landing in 2028.

“We are certainly humbled as a crew to be able to be your crew that executes this Artemis III mission in space,” said Bresnik, Artemis III commander.

Added Douglas, mission specialist: “My brain — it is going a mile a minute right now. But my heart, it is so warm. It is so full."

In May, NASA awarded hundreds of millions of dollars in contracts to four companies, including Blue Origin, to build landers, rovers and drones for a future moon base. Isaacman said the goal of the moon base is to lay the foundation for a Mars expedition.

Meta to bring $115 million AI data center training initiative to Houston

ai workforce

Meta and Associated Builders and Contractors have entered into a partnership to invest $115 million in training programs for the construction of AI data centers, with a portion of the project launching in Houston.

The companies announced June 8 that they would open America’s Workforce Academies at ABC chapter training centers in Houston; Indianapolis; Baton Rouge, Louisiana; and Columbus, Ohio.

The academies will offer career readiness and safety training, plus five weeks of hands-on education. Participants who complete the program will be granted a job offer from contractors working on Meta projects.

“The AI revolution is bringing change but also historic opportunities,” Dina Powell McCormick, Meta president and vice-chairman, said in a news release. “Skilled workers electrified rural America one pole at a time. They manned the factories that built the arsenal that won World War II. Now a new generation will pour the foundations and lay the fiber that secures American strength in this new age.”

Overall, the Meta and ABC aim for the academies to build a more sustainable pipeline of skilled construction workers and ensure safety and job readiness for the surging number of data center projects underway.

“This new program is an innovative talent solution that is a critical part of addressing the construction industry’s ongoing workforce shortage and creates an accelerated, new-entrant strategy for job seekers ... The sustained demand for data center construction technicians means the industry needs an all-of-the-above approach to address this shortage and grow the construction talent pool,” Michael Bellaman, ABC president and CEO, added in the release.

In Texas, Meta, the parent company of Facebook and Instagram, has launched or broken ground on data centers in El Paso, Fort Worth and Temple. The company announced in March that it planned to grow its El Paso Data center by 1 gigawatt, representing more than a $10 billion investment.

Apart from Meta, Texas has attracted data center development to power other giants like Google and Amazon in recent years. In turn, Texas has been predicted to become the biggest data center market. Commercial real estate services provider JLL reported this spring that the state could topple Northern Virginia as the world’s largest data-center market by 2030. Similarly, CBRE predicted that Houston's data center capacity could double by 2028. Read more here.

New Houston biotech co. lands $30M for pulmonary fibrosis drug

drug money

Most of us can claim a scar or two on our bodies. But when scarring develops inside the body, it’s known as a fibrotic disorder. A freshly launched Houston company, Oorja Bio Inc., is working on a treatment that can help to repair cells and reduce the damage wrought by the growth of fibrotic tissue in patients.

Late last month, Oorja Bio hit the scene with a pair of big announcements. Not only has the company raised a $30 million Series A thanks to founding investor California-based Westlake BioPartners, but it has also already paved the way for a Phase 2 study to take place this year.

Oorja Bio received Investigational New Drug (IND) clearance from the U.S. Food and Drug Administration (FDA), allowing the company to test its treatment in patients with idiopathic pulmonary fibrosis (IPF), a scarring of the lung tissue. IPF affects more than 150,000 adults in the United States and can result in a range of symptoms from shortness of breath to organ failure and death as it progresses.

Oorja Bio’s lead drug candidate, ORJ-001, was shown in a Phase 1 in-human trial to demonstrate “therapeutically relevant exposure and favorable tolerability” in 64 healthy adult volunteers in whom it was administered daily or weekly, according to a news release. Pre-clinical studies of ORJ-001 showed durable target tissue engagement and biomarker activity in bleomycin-induced lung fibrosis.

Administered subcutaneously, ORJ-001 is intended to improve and even restore function in cells that can reduce the signaling that causes IPF. It stops advancement of IPF and also allows for tissue repair. Currently available treatments for the disease can slow the development of IPF down, but do not address the declining lung function that’s inherent in its progression.

“The clinical and preclinical results from our studies to date give us confidence that ORJ-001 represents a novel treatment approach with the potential to repair and reverse fibrosis and modify disease progression in IPF,” Dr. Janethe Pena, CMO of Oorja Bio, said in the release.

“Our team is energized to deliver on our goal of redefining the future of fibrotic diseases, beginning with ORJ-001,” CEO and founder Sujay Kango added. “As we advance ORJ-001 in the clinic, we are embracing the paradigm shift in our biological understanding of IPF pathology that aligns with the central role of the alveolar epithelium. ORJ-001 was designed with this biology in mind and may provide, for the first time, a therapeutic intervention that repairs and reverses fibrosis and promotes disease modification.”

Most patients live only three to five years following their IPF diagnosis. Soon, ORJ-001 and Oorja Bio could give them a fighting chance.